Resultats de la cerca - David A. Morrow

Refinar resultats
  1. 1
    Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

    Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease per David A. Morrow

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes<SUBTITLE>The MERLIN-TIMI 36 Randomized Trial</SUBTITLE>

    Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes<SUBTITLE>The MERLIN-TIMI 36 Randomized Trial</SUBTITLE&... per David A. Morrow

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Future of Biomarkers in Acute Coronary Syndromes

    Future of Biomarkers in Acute Coronary Syndromes per David A. Morrow, Eugene Braunwald

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  4. 4
    Unstable Angina

    Unstable Angina per Eugene Braunwald, David A. Morrow

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Evaluation of High-Sensitivity Assays for Cardiac Troponin

    Evaluation of High-Sensitivity Assays for Cardiac Troponin per David A. Morrow, Elliott M. Antman

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  6. 6
    Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes

    Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes per James A. de Lemos, David A. Morrow

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  7. 7
    Inflammatory Biomarkers in Acute Coronary Syndromes

    Inflammatory Biomarkers in Acute Coronary Syndromes per Ehrin J. Armstrong, David A. Morrow, Marc S. Sabatine

    Publicat 2006
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved Sensitivity

    Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved Sensitivity per Stacy E.F. Melanson, David A. Morrow, Petr Jarolı́m

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Highly Sensitive Troponin Assays and the Cardiology Community: A Love/Hate Relationship?

    Highly Sensitive Troponin Assays and the Cardiology Community: A Love/Hate Relationship? per James A. de Lemos, David A. Morrow, Christopher R. deFilippi

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    The Search for a Biomarker of Cardiac Ischemia

    The Search for a Biomarker of Cardiac Ischemia per David A. Morrow, James A. de Lemos, Marc S. Sabatine, Elliott M. Antman

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  11. 11
    Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction

    Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American He... per Allan S. Jaffe, Fred S. Apple, David A. Morrow, Bertil Lindahl, Hugo A. Katus

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Identification of Genetic Variants Associated With Response to Statin Therapy

    Identification of Genetic Variants Associated With Response to Statin Therapy per Jessica L. Mega, David A. Morrow, Alison Brown, Christopher P. Cannon, Marc S. Sabatine

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35

    Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 per Marc S. Sabatine, David A. Morrow, James A. de Lemos, Petr Jarolı́m, Eugene Braunwald

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial

    Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial per Petr Jarolı́m, William B. White, Christopher P. Cannon, Qi Gao, David A. Morrow

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    COVID-19 for the Cardiologist

    COVID-19 for the Cardiologist per Deepak Atri, Hasan K. Siddiqi, Joshua Lang, Victor Nauffal, David A. Morrow, Erin A. Bohula

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  16. 16
    Cardiogenic Shock After Acute Myocardial Infarction

    Cardiogenic Shock After Acute Myocardial Infarction per Marc D. Samsky, David A. Morrow, Alastair Proudfoot, Judith S. Hochman, Hölger Thiele, Sunil V. Rao

    Publicat 2021
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  17. 17
    An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

    An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS per David A. Morrow, Elliott M. Antman, Steven Snapinn, Carolyn H. McCabe, Pierre Théroux, Eugene Braunwald

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes

    Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndro... per Kausik K. Ray, Christopher P. Cannon, Richard Cairns, David A. Morrow, Paul M. Ridker, Eugene Braunwald

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    A current review of COVID-19 for the cardiovascular specialist

    A current review of COVID-19 for the cardiovascular specialist per Joshua Lang, Xiaowen Wang, Filipe A. Moura, Hasan K. Siddiqi, David A. Morrow, Erin A. Bohula

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  20. 20
    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy

    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy per Stephen D. Wiviott, Christopher P. Cannon, David A. Morrow, Kausik K. Ray, Marc A. Pfeffer, Eugene Braunwald

    Publicat 2005
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: